Coba Tambahkan “Ini” ke Dalam Mesin Cuci, Semua Kotoran Langsung “Terangkat Seketika”! 90% Orang Belum Tahu Tips Ajaib Ini!
Researchers from Japan found a replacement immunohistochemical marker, glypican-1, which will be wont to differentiate cases of epithelioid carcinoma from respiratory organ glandular carcinoma. They explained histologic morphology, or cell kind, isn't enough on its own to properly create a carcinoma diagnosing or be able to develop the foremost effective treatment arrange.
Mesothelioma is usually misdiagnosed as alternative cancers and diseases, with respiratory organ glandular carcinoma among the foremost common since it additionally expresses alternative common markers of carcinoma. glandular carcinoma, the foremost common sort of carcinoma, is additionally usually created from organ animal tissue cells. Since five hundredth – seventieth of carcinoma cases square measure created from the somatic cell kind and most ordinarily found within the lining of the respiratory organ, properly differentiating these 2 cancers is quite troublesome. specialists mostly agree that the simplest thanks to accurately differentiate 2 similar diagnoses is thru researching specific cellular stains beneath a magnifier.
Glypican-1 may be a supermolecule that has already been known as a marker for alternative cancers, like carcinoma. alternative studies have additionally alluded to the thought that the supermolecule plays an outsized role in cellular division and growth regulation. to work out if the supermolecule may additionally be a marker of epithelioid carcinoma, the researchers studied eighty two carcinoma patients and ninety seven cases of respiratory organ glandular carcinoma for expression of the supermolecule.
BACA HALAMAN SELANJUTNYA
Loading...
Loading...